Key result
Managing cardiovascular risk in dementia requires individualized assessment because standard tools overestimate MACE prevention benefits.
Why the study?
Current cardiovascular risk management guidelines are based on trials that excluded persons with dementia, in whom the beneficial and harmful effects of treatment may differ from older persons without cognitive impairment.
How should cardiovascular risk management guidelines be translated and applied to persons with dementia to prevent MACE?
Population
Persons with dementia
Design
Narrative review
Authors
Loading...
Requires individualized CV risk assessment in dementia; leaves open dementia-specific guidelines and trials.
How should cardiovascular risk management guidelines be translated and applied to persons with dementia to prevent MACE?
Cardiovascular risk management in persons with dementia requires individualized approaches, careful use of risk assessment tools, and consideration of deprescribing due to shorter life expectancy and higher risk of adverse drug events.
Nijskens et al. (2023) conducted a review in Dementia and cardiovascular risk. Cardiovascular risk management was evaluated. Cardiovascular risk management in persons with dementia requires individualized assessment of life expectancy and treatment wishes, as standard risk tools may overestimate the benefits of preventing MACE.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: